Qiagen NV | QIA - 债务

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.62B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	债务	更改		日
Akebia Therapeutics	USD 46.51M		7.82M	2025-03
Alaunos Therapeutics	USD 10.99M		5.78M	2023-03
argenx SE	USD 47.16M		4.01M	2025-12
Avita Medical	AUD 46.05M		1.46M	2025-12
Dianthus Therapeutics	USD 1.36M		79K	2026-03
Ionis Pharmaceuticals	USD 1.91B		425.5M	2026-06
IQVIA Holdings	USD 16.24B		408M	2026-06
Moderna	USD 1.3B		7M	2026-03
Organon & Co	USD 8.55B		16M	2026-06
Qiagen NV	USD 1.65B		165.82M	2026-03
Revvity	USD 3.35B		48.03M	2026-03
Tectonic Therapeutic	USD 876K		115K	2024-12
Viatris	USD 13.35B		993.3M	2026-06
Xeris Pharmaceuticals	USD 258.55M		899K	2026-03